BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis
USA - NYSE:BKD - US1124631045 - Common Stock
10.67 USD
+0.19 (+1.81%)
Overall BKD gets a fundamental rating of 1 out of 10. We evaluated BKD against 100 industry peers in the Health Care Providers & Services industry. BKD may be in some trouble as it scores bad on both profitability and health. BKD has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BKD has reported negative net income.
BKD had a positive operating cash flow in the past year.
In the past 5 years BKD reported 4 times negative net income.
Of the past 5 years BKD 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.95%, BKD is doing worse than 66.00% of the companies in the same industry.
BKD has a worse Return On Equity (-230.26%) than 80.00% of its industry peers.
BKD has a worse Return On Invested Capital (0.88%) than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.95% | ||
| ROE | -230.26% | ||
| ROIC | 0.88% |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BKD's Operating Margin of 1.94% is in line compared to the rest of the industry. BKD outperforms 47.00% of its industry peers.
BKD's Operating Margin has improved in the last couple of years.
BKD has a Gross Margin (25.98%) which is in line with its industry peers.
In the last couple of years the Gross Margin of BKD has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.94% | ||
| PM (TTM) | N/A | ||
| GM | 25.98% |
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BKD is destroying value.
The number of shares outstanding for BKD has been increased compared to 1 year ago.
Compared to 5 years ago, BKD has more shares outstanding
Compared to 1 year ago, BKD has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.16, we must say that BKD is in the distress zone and has some risk of bankruptcy.
BKD has a Altman-Z score of -0.16. This is amonst the worse of the industry: BKD underperforms 80.00% of its industry peers.
A Debt/Equity ratio of 40.40 is on the high side and indicates that BKD has dependencies on debt financing.
The Debt to Equity ratio of BKD (40.40) is worse than 84.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 40.4 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.16 |
ROIC/WACC0.1
WACC8.74%
2.3 Liquidity
A Current Ratio of 0.83 indicates that BKD may have some problems paying its short term obligations.
BKD's Current ratio of 0.83 is on the low side compared to the rest of the industry. BKD is outperformed by 85.00% of its industry peers.
BKD has a Quick Ratio of 0.83. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
BKD has a Quick ratio of 0.83. This is in the lower half of the industry: BKD underperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
The earnings per share for BKD have decreased strongly by -11.96% in the last year.
BKD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.64%.
Measured over the past years, BKD shows a decrease in Revenue. The Revenue has been decreasing by -5.08% on average per year.
EPS 1Y (TTM)-11.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.7%
3.2 Future
BKD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.30% yearly.
Based on estimates for the next years, BKD will show a small growth in Revenue. The Revenue will grow by 0.82% on average per year.
EPS Next Y9.78%
EPS Next 2Y19.93%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue Next Year2.5%
Revenue Next 2Y-0.02%
Revenue Next 3Y0.82%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BKD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
BKD's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 14.84 |
4.3 Compensation for Growth
BKD's earnings are expected to grow with 17.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.93%
EPS Next 3Y17.3%
5. Dividend
5.1 Amount
BKD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:BKD (11/21/2025, 1:55:43 PM)
10.67
+0.19 (+1.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.97%
Inst Owner Change1.65%
Ins Owners0.79%
Ins Owner Change0.03%
Market Cap2.53B
Revenue(TTM)3.13B
Net Income(TTM)-242.65M
Analysts51.67
Price Target7.75 (-27.37%)
Short Float %5.31%
Short Ratio3.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.95%
Min EPS beat(2)-145.33%
Max EPS beat(2)-30.56%
EPS beat(4)0
Avg EPS beat(4)-69%
Min EPS beat(4)-145.33%
Max EPS beat(4)-25.67%
EPS beat(8)1
Avg EPS beat(8)-43.41%
EPS beat(12)4
Avg EPS beat(12)-13.85%
EPS beat(16)6
Avg EPS beat(16)6.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)-1.36%
Revenue beat(4)0
Avg Revenue beat(4)-1.25%
Min Revenue beat(4)-1.56%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-1.07%
Revenue beat(12)0
Avg Revenue beat(12)-0.91%
Revenue beat(16)0
Avg Revenue beat(16)-0.97%
PT rev (1m)1.33%
PT rev (3m)1.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.27%
EPS NY rev (1m)1.33%
EPS NY rev (3m)-8.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.79 | ||
| P/FCF | N/A | ||
| P/OCF | 11.59 | ||
| P/B | 24.05 | ||
| P/tB | 32.46 | ||
| EV/EBITDA | 14.84 |
EPS(TTM)-1.03
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)0.92
OCFY8.63%
SpS13.44
BVpS0.44
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.95% | ||
| ROE | -230.26% | ||
| ROCE | 1.11% | ||
| ROIC | 0.88% | ||
| ROICexc | 0.92% | ||
| ROICexgc | 0.92% | ||
| OM | 1.94% | ||
| PM (TTM) | N/A | ||
| GM | 25.98% | ||
| FCFM | N/A |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score5
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 40.4 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.64 | ||
| Cap/Depr | 163.45% | ||
| Cap/Sales | 19.46% | ||
| Interest Coverage | 0.25 | ||
| Cash Conversion | 49.49% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | -0.16 |
F-Score5
WACC8.74%
ROIC/WACC0.1
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y9.78%
EPS Next 2Y19.93%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue 1Y (TTM)3.64%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.7%
Revenue Next Year2.5%
Revenue Next 2Y-0.02%
Revenue Next 3Y0.82%
Revenue Next 5YN/A
EBIT growth 1Y24.43%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year535.01%
EBIT Next 3Y90.96%
EBIT Next 5YN/A
FCF growth 1Y-274.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.46%
OCF growth 3YN/A
OCF growth 5Y-5.14%
BROOKDALE SENIOR LIVING INC / BKD FAQ
What is the ChartMill fundamental rating of BROOKDALE SENIOR LIVING INC (BKD) stock?
ChartMill assigns a fundamental rating of 1 / 10 to BKD.
What is the valuation status for BKD stock?
ChartMill assigns a valuation rating of 1 / 10 to BROOKDALE SENIOR LIVING INC (BKD). This can be considered as Overvalued.
How profitable is BROOKDALE SENIOR LIVING INC (BKD) stock?
BROOKDALE SENIOR LIVING INC (BKD) has a profitability rating of 2 / 10.
Can you provide the financial health for BKD stock?
The financial health rating of BROOKDALE SENIOR LIVING INC (BKD) is 0 / 10.
Can you provide the expected EPS growth for BKD stock?
The Earnings per Share (EPS) of BROOKDALE SENIOR LIVING INC (BKD) is expected to grow by 9.78% in the next year.